Efficacy and safety of glecaprevir/pibrentasvir in renally-impaired patients with chronic hepatitis C virus genotype 1–6 infection

Autor:	Marcus-Alexander Wörns, Jun Yong Park, J. Rullman, Marcello Persico, Manal Abunimeh, A. Pocalla, Robert Flisiak, Eric Lawitz, Andrea Aglitti, Meghan E. Sise, M. Kaskas, Annette Bruchfeld, Z. Xue
Rok vydání:	2018
Předmět:	03 medical and health sciences 0302 clinical medicine Hepatology Chronic hepatitis business.industry Genotype Immunology 030232 urology & nephrology Medicine 030211 gastroenterology & hepatology Glecaprevir / pibrentasvir business Virus
Zdroj:	Journal of Hepatology. 68:S292
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(18)30803-1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a31fb48eee9ec061c6eff13d7a21c167 https://doi.org/10.1016/s0168-8278(18)30803-1 Zobrazit plný text záznamu Full Text from ScienceDirect